Reinbold named managing director of Advanced Diagnostics and Therapeutics Initiative at Notre Dame

Author: William G. Gilroy and Nina Welding

Kirk Reinbold

Kirk A. Reinbold has been named managing director of the Advanced Diagnostics and Therapeutics (AD&T) Initiative at the University of Notre Dame.

Created last year, the AD&T designs micro-sensing devices for personalized health care and environmental monitoring. Working on the nanoscale, researchers from chemical and biomolecular engineering, computer science and engineering, electrical engineering, biological sciences, and chemistry and biochemistry are developing miniaturized systems that can capture and detect a few distinct molecules in order to provide physicians and scientists with more accurate information for medical diagnoses or environmental assessments.

In this newly created position, Reinbold serves as the chief operating officer of the AD&T and is responsible for managing the activities of the initiative, including the development of relationships with foundations, government agencies and university and commercial partners, including large companies and start-up ventures. He oversees complex multi-investigator proposals from development through funding dispersal, as well as the activities of 24 principal investigators and numerous other researchers and support staff.

The addition of a managing director was critical to the initiative, according to Paul W. Bohn, Arthur J. Schmitt Professor of Chemical and Biomolecular Engineering and director of the AD&T.

“In filling this pivotal position we are very pleased to have found Kirk Reinbold,” Bohn said. “He brings just the right experience and skills to help the AD&T forge crucial connections to partners in Indiana and the rest of the U.S.”

“Kirk Reinbold is a key piece of the exciting AD&T initiative,” said Robert J. Bernhard, vice president for research. “He will help us translate Notre Dame discoveries to practice, as well as play a role in helping interested external parties connect to the correct places within AD&T.”

Reinbold previously served on the Scientific Advisory Board of a telehealth company that develops at-home monitoring systems and on the board of directors for a land conservation trust. He also served as senior consultant and medical science liaison for MedTech Solutions, where his duties included developing and managing intellectual property and providing technology assessment and early-stage business development strategies to both investors and entrepreneurs.

Reinbold holds several patents for inventions related to neurological impairment rehabilitation, osteoarthritis management and sports performance monitoring. He is a senior scholar at Thomas Jefferson University School of Population Health, a member of the Aerospace Medical Association and serves on the Physical Sciences Technology Advisory Committee of Ben Franklin Technology Partners.

A graduate of the University of Rochester, Reinbold earned his master’s degree from the University of North Carolina and his doctorate from the University of Pennsylvania.